In the News

The Situation: The Discovery PK group in a major pharmaceutical company saw continued increases in the volume of in vivo studies requested by research groups and they were struggling to keep up with the demand at the quality levels they set for themselves. Much of the process was held together by human capital moving data from system to system rather than automation. The company was looking for investment options to improve throughput, quality, and access to PK results.